Not applicableUnknownNCT03352739What this trial is testingFornix and NbM as Targets of Stimulation In Alzheimer's DiseaseWho this might be right forAlzheimer Disease Xuanwu Hospital, Beijing 30
Testing effectiveness (Phase 2)Study completedNCT02423122What this trial is testingA PET Study of the Effects of p38 MAP Kinase Inhibitor, VX-745, on Amyloid Plaque Load in Alzheimer's Disease (AD)Who this might be right forAlzheimer's DiseaseMild Cognitive Impairment EIP Pharma Inc 16
Large-scale testing (Phase 3)Looking for participantsNCT06534723What this trial is testingPhase 3 Clinical Trial of Wujia Yizhi Granules in the Treatment of Mild-to-moderate Alzheimer's Dementia (Syndrome of Deficiency of Spleen and Kidney)Who this might be right forAlzheimer's Dementia Sichuan Jishengtang Pharmaceutical Co., Ltd. 570
Not applicableStudy completedNCT02860338What this trial is testingCOMPARATIVE EFFECTIVENESS OF MCI and DEMENTIA TREATMENTS IN A COMMUNITY-BASED DEMENTIA PRACTICEWho this might be right forMild Cognitive ImpairmentDementiaHypoxia+14 more Clionsky Neuro Systems Inc. 900
Testing effectiveness (Phase 2)Study completedNCT04388254What this trial is testingSimufilam (PTI-125), 100 mg, for Mild-to-moderate Alzheimer's Disease PatientsWho this might be right forAlzheimer Disease Cassava Sciences, Inc. 220
Post-approval studies (Phase 4)Study completedNCT01047579What this trial is testingA 12 Week, Multicenter, Open Label Evaluation of Caregiver Preference, Safety and Tolerability of Exelon® Patch (Rivastigmine Transdermal) in Patients With Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Novartis Pharmaceuticals 51
Early research (Phase 1)Study completedNCT03277573What this trial is testingSalsalate in Patients Mild to Moderate Alzheimer's DiseaseWho this might be right forAlzheimer Disease Adam Boxer 40
Large-scale testing (Phase 3)WithdrawnNCT01211782What this trial is testingAC-1204 Long-term Efficacy Response Trial (ALERT Protocol)Who this might be right forAlzheimer's Disease Cerecin
Not applicableUnknownNCT03288363What this trial is testingTranscranial Direct Current Stimulation and Early Alzheimer's Disease (tDCS-AD)Who this might be right forAlzheimer Disease Benjamin CALVET 80
Testing effectiveness (Phase 2)Looking for participantsNCT06362707What this trial is testingFasudil Trial for Treatment of Early Alzheimer's Disease (FEAD)Who this might be right forCognitive Decline, MildAlzheimer Disease Helse Stavanger HF 200
Large-scale testing (Phase 3)Study completedNCT01047254What this trial is testingBupropion for the Treatment of Apathy in Alzheimer's DementiaWho this might be right forApathy in Dementia University Hospital, Bonn 110
Post-approval studies (Phase 4)Study completedNCT00234637What this trial is testingRivastigmine Monotherapy and Combination Therapy With Memantine in Patients With Moderately Severe Alzheimer's Disease Who Failed to Benefit From Previous Cholinesterase Inhibitor TreatmentWho this might be right forAlzheimer's Disease Novartis 204
Large-scale testing (Phase 3)Study completedNCT01862640What this trial is testingA Phase 3, 12-week, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of 2 Fixed Doses of Brexpiprazole in the Treatment of Alzheimer's AgitationWho this might be right forAgitation Associated WithAlzheimer's DiseaseAlzheimer's Type+2 more Otsuka Pharmaceutical Development & Commercialization, Inc. 433
Post-approval studies (Phase 4)WithdrawnNCT00711204What this trial is testingEvaluating The Impact Of Donepezil Hydrochloride (Aricept) On Behavioral And Psychological Symptoms In Patients With Severe Alzheimer's DiseaseWho this might be right forSevere Alzheimer's Disease Eisai Inc.
Testing effectiveness (Phase 2)Study completedNCT02240693What this trial is testingAlzheimer Disease Proof of Concept Study With BI 409306 Versus PlaceboWho this might be right forAlzheimer Disease Boehringer Ingelheim 128
Testing effectiveness (Phase 2)Study completedNCT02244541What this trial is testingPhase 2a Dose Finding, PK/PD and 12 Month Exploratory Efficacy Study of ANAVEX2-73 in Patients With Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Anavex Life Sciences Corp. 32
Not applicableStudy completedNCT04771845What this trial is testingTranscranial Magnetic Stimulation in Mild Cognitive Impairment and Alzheimer DiseaseWho this might be right forAlzheimer DiseaseMild Cognitive Impairment The New York Memory Services 73
Very early researchStudy completedNCT01024660What this trial is testingThe Effect of Cognitive Function as Measured by Repeated Cognitive Measures After 12 Weeks Treatment With DonepezilWho this might be right forAlzheimer's Disease AstraZeneca 155
Not applicableStudy completedNCT03622905What this trial is testingADvance II Study: DBS-f in Patients With Mild Alzheimer's DiseaseWho this might be right forAlzheimer Disease Functional Neuromodulation Ltd 74
Large-scale testing (Phase 3)Study completedNCT03548584What this trial is testingA Trial to Evaluate the Safety, Efficacy, and Tolerability of Brexpiprazole in Treating Agitation Associated With Dementia of the Alzheimer's TypeWho this might be right forAgitation Associated With Alzheimer's DementiaAlzheimer Dementia Otsuka Pharmaceutical Development & Commercialization, Inc. 345